Clove extract inhibits tumor growth and promotes cell cycle arrest and apoptosis

Oncology Research

Volumn 21, Issue 5, 2013, Pages 247-259

  Liu, Haizhou ^a,b,c   Schmitz, John C ^b,c   Wei, Jianteng ^a   Cao, Shousong ^d   Beumer, Jan H ^c,e   Strychor, Sandra ^c   Cheng, Linyou ^a   Liu, Ming ^a   Wang, Cuicui ^a   Wu, Ning ^a   Zhao, Xiangzhong ^a   Zhang, Yuyan ^a   Liao, Joshua ^f   Chu, Edward ^b,c   Lin, Xiukun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Colorectal cancer; Oleanolic acid (OA); Syzygium aromaticum; Traditional Chinese medicine

Indexed keywords

ANTINEOPLASTIC AGENT; EUGENOL; FLUOROURACIL; HISTONE H2AX; HISTONE H2AX GAMMA; MESSENGER RNA; OLEANOLIC ACID; PLANT EXTRACT; PROTEIN P21; RETINOBLASTOMA PROTEIN; SURVIVIN; SYZYGIUM AROMATICUM EXTRACT; THYMIDYLATE SYNTHASE; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELLULAR DISTRIBUTION; CLOVE; COLON ADENOCARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DOWN REGULATION; DRUG EFFECT; DRUG IDENTIFICATION; DRUG POTENCY; EMBRYO; ENZYME REPRESSION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GROWTH INHIBITION; HT 29 CELL LINE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER CELL LINE; MCF 7 CELL LINE; MOUSE; NONHUMAN; OVARIAN CANCER CELL LINE; PANCREATIC CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; TREATMENT DURATION; TREATMENT OUTCOME; WEIGHT REDUCTION; ANIMAL; CELL CYCLE CHECKPOINT; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; EUGENIA; HELA CELL LINE; NEOPLASMS; NUDE MOUSE; PATHOLOGY; RANDOMIZATION; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; EUGENIA; FEMALE; HELA CELLS; HT29 CELLS; HUMANS; MCF-7 CELLS; MICE; MICE, NUDE; NEOPLASMS; PLANT EXTRACTS; RANDOM ALLOCATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84907542721     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504014X13946388748910     Document Type: Article

References (29)

1. Jemal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin. 61:69-90; 2011.
2. Wyld, L.; Reed, M. The role of surgery in the management of older women with breast cancer. Eur. J. Cancer 43:2253-2263; 2007.
3. Newman, D. J.; Cragg, G. M.; Snader, K. M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 66:1022-1037; 2003.
4. Huang, X. H.; Xiong, P. C.; Xiong, C. M.; Cai, Y. L.; Wei, A. H.; Wang, J. P.; Liang, X. F.; Ruan, J. L. In vitro and in vivo antitumor activity of Macrothelypteris torresiana and its acute/subacute oral toxicity. Phytomedicine 17:930-934; 2010.
5. Park, I. K.; Shin, S. C. Fumigant activity of plant essential oils and components from garlic (Allium sativum) and clove bud (Eugenia caryophyllata) oils against the Japanese termite (Reticulitermes speratus Kolbe). J. Agric. Food Chem. 53:4388-4392; 2005.
6. Bu, T.; Liu, M.; Zheng, L.; Guo, Y.; Lin, X. alpha-Glucosidase inhibition and the in vivo hypoglycemic effect of butyl-isobutyl-phthalate derived from the Laminaria japonica rhizoid. Phytother. Res. 24:1588-1591; 2010.
7. Ganbold, M.; Barker, J.; Ma, R.; Jones, L.; Carew, M. Cytotoxicity and bioavailability studies on a decoction of Oldenlandia diffusa and its fractions separated by HPLC. J. Ethnopharmacol. 131:396-403; 2010.
8. Wang, Z.; Zheng, L.; Yang, S.; Niu, R.; Chu, E.; Lin, X. N-acetylchitooligosaccharide is a potent angiogenic inhibitor both in vivo and in vitro. Biochem. Biophys. Res. Commun. 357:26-31; 2007.
9. Cao, S.; Durrani, F. A.; Rustum, Y. M. Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clin. Cancer Res. 10:2561-2569; 2004.
10. Sun, F. X.; Tohgo, A.; Bouvet, M.; Yagi, S.; Nassirpour, R.; Moossa, A. R.; Hoffman, R. M. Efficacy of camptothecin analog DX-8951f (Exatecan Mesylate) on human pancreatic cancer in an orthotopic metastatic model. Cancer Res. 63:80-85; 2003.
11. Hou, J.; Wang, D.; Zhang, R.; Wang, H. Experimental therapy of hepatoma with artemisinin and its derivatives: In vitro and in vivo activity, chemosensitization, and mechanisms of action. Clin. Cancer Res. 14:5519-5530; 2008.
12. Schmitz, J. C.; Chu, E. Effect of small interfering RNA 3'-end overhangs on chemosensitivity to thymidylate synthase inhibitors. Silence 2:1; 2011.
13. Pereira, D. A.; Dalmarco, J. B.; Wisniewski, Jr., A.; Simionatto, E. L.; Pizzolatti, M. G.; Frode, T. S. Lotus corniculatus regulates the inflammation induced by bradykinin in a murine model of pleurisy. J. Agric. Food Chem. 59:2291-2298; 2011.
14. Juan, M. E.; Planas, J. M.; Ruiz-Gutierrez, V.; Daniel, H.; Wenzel, U. Antiproliferative and apoptosis-inducing effects of maslinic and oleanolic acids, two pentacyclic triterpenes from olives, on HT-29 colon cancer cells. Br. J. Nutr. 100:36-43; 2008.
15. Lucio, K. A.; Rocha Gda, G.; Moncao-Ribeiro, L. C.; Fernandes, J.; Takiya, C. M.; Gattass, C. R. Oleanolic acid initiates apoptosis in non-small cell lung cancer cell lines and reduces metastasis of a B16F10 melanoma model in vivo. PLoS One 6:e28596; 2011.
16. Hussain, A.; Brahmbhatt, K.; Priyani, A.; Ahmed, M.; Rizvi, T.A.; Sharma, C. Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and anti-inflammatory activity in human cervical cancer cells. Cancer Biother. Radiopharm. 26:519-527; 2011.
17. Amico, V.; Barresi, V.; Chillemi, R.; Condorelli, D. F.; Sciuto, S.; Spatafora, C.; Tringali, C. Bioassay-guided isolation of antiproliferative compounds from grape (Vitis vinifera) stems. Nat. Prod. Commun. 4:27-34; 2009.
18. Liu, J. Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. 49:57-68; 1995.
19. Wei, J.; Liu, M.; Liu, H.; Wang, H.; Wang, F.; Zhang, Y.; Han, L.; Lin, X. Oleanolic acid arrests cell cycle and induces apoptosis via ROS-mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreatic cancer cells. J. Appl. Toxicol. 33:756-765; 2013.
20. Lu, Y. F.; Wan, X. L.; Xu, Y.; Liu, J. Repeated oral administration of oleanolic acid produces cholestatic liver injury in mice. Molecules 18:3060-3071; 2013.
21. Prasad, S.; Yadav, V. R.; Sung, B.; Reuter, S.; Kannappan, R.; Deorukhkar, A.; Diagaradjane, P.; Wei, C.; Baladandayuthapani, V.; Krishnan, S.; Guha, S.; Aggarwal, B. B. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: Chemosensitization with capecitabine. Clin. Cancer Res. 18:4942-4953; 2012.
22. Wei, J.; Liu, H.; Liu, M.; Wu, N.; Zhao, J.; Xiao, L.; Han, L.; Chu, E.; Lin, X. Oleanolic acid potentiates the antitumor activity of 5-fluorouracil in pancreatic cancer cells. Oncol. Rep. 28:1339-1345; 2012.
23. Nam, W.; Tak, J.; Ryu, J. K.; Jung, M.; Yook, J. I.; Kim, H. J.; Cha, I. H. Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. Head Neck 29:335-340; 2007.
24. Harper, J. W.; Elledge, S. J.; Keyomarsi, K.; Dynlacht, B.; Tsai, L. H.; Zhang, P.; Dobrowolski, S.; Bai, C.; Connell-Crowley, L.; Swindell, E.; et al. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387-400; 1995.
25. Deshpande, A.; Sicinski, P.; Hinds, P. W. Cyclins and cdks in development and cancer: A perspective. Oncogene 24:2909-2915;2005.
26. DeGregori, J.; Kowalik, T.; Nevins, J.R. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis-and G1/S-regulatory genes. Mol. Cell Biol. 15:4215-4224; 1995.
27. Pratheeshkumar, P.; Kuttan, G. Oleanolic acid induces apoptosis by modulating p53, Bax, Bcl-2 and caspase-3 gene expression and regulates the activation of transcription factors and cytokine profile in B16F. J. Environ. Pathol. Toxicol. Oncol. 30:21-31; 2011.
28. Ahmad, N.; Adhami, V. M.; Afaq, F.; Feyes, D. K.; Mukhtar, H. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin. Cancer Res. 7:1466-1473; 2001.
29. Roy, S.; Kaur, M.; Agarwal, C.; Tecklenburg, M.; Sclafani, R. A.; Agarwal, R. p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells. Mol. Cancer Ther. 6:2696-2707; 2007.